-
公开(公告)号:EP4422608A1
公开(公告)日:2024-09-04
申请号:EP22888189.2
申请日:2022-10-27
IPC分类号: A61K31/015 , A61K31/13 , A61K31/138 , A61K31/045
CPC分类号: A61K31/138
-
公开(公告)号:EP4355307A2
公开(公告)日:2024-04-24
申请号:EP22736011.2
申请日:2022-06-12
发明人: BENNY, Ofra , AMOYAV, Ben Zion
IPC分类号: A61K9/16 , A61K31/135 , A61K31/704 , A61K49/04 , A61K9/50 , A61K9/00 , A61K31/13 , A61K31/70 , A61K9/19
CPC分类号: A61K9/5031 , A61K9/5089 , A61K9/19 , A61K9/0019 , A61P35/00 , A61K9/5052 , A61K9/5057 , A61K9/5036 , A61K9/1641 , A61K9/1647 , A61K9/1635 , A61K49/048 , A61K31/53 , A61K31/136 , A61K31/407 , A61L24/04 , A61L24/001 , A61L2430/3620130101 , A61L24/046 , A61L2400/1220130101 , A61L24/0015 , A61L24/0036
-
公开(公告)号:EP4329737A1
公开(公告)日:2024-03-06
申请号:EP22796924.3
申请日:2022-05-02
IPC分类号: A61K31/13 , A61K31/165 , A61K31/4515
-
公开(公告)号:EP4297739A1
公开(公告)日:2024-01-03
申请号:EP22706927.5
申请日:2022-02-19
-
-
公开(公告)号:EP4262848A1
公开(公告)日:2023-10-25
申请号:EP21908034.8
申请日:2021-12-15
发明人: OSTROV, David A. , NORRIS, Michael
-
公开(公告)号:EP4248958A2
公开(公告)日:2023-09-27
申请号:EP23191736.0
申请日:2022-01-27
申请人: Priothera SAS , Priothera Limited
IPC分类号: A61K31/13
摘要: The present invention relates to S1P receptor modulators, preferably mocravimod, for use in treating patients suffering from acute myelogenous leukemia (AML) and who have undergone allogeneic hematopoietic stem cell transplantation (HSCT). The invention relates in particular to methods of treating AML in subjects undergoing HSCT, wherein said method comprises daily administering an efficient amount of S1P receptor modulator, preferably mocravimod, to said subject in need thereof, for at least 6 months, preferably at least 12 months.
-
公开(公告)号:EP4194435A1
公开(公告)日:2023-06-14
申请号:EP21853226.5
申请日:2021-08-06
IPC分类号: C07C49/753 , A61K31/075 , A61K31/122 , A61K31/13 , A61K31/16 , A61K31/27 , A61K31/275 , A61P13/10 , A61P21/00 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/28 , A61P29/02 , A61P43/00 , C07C235/78 , C07C255/31 , C07C271/12
摘要: Provided are a compound represented by formula (I) or a salt thereof, a nerve growth promoter containing the compound or a salt thereof as an active ingredient, a pharmaceutical composition containing the compound or a salt thereof, a therapeutic agent for neurodegenerative diseases containing the compound or a salt thereof as an active ingredient, a therapeutic agent for amyotrophic lateral sclerosis containing the compound or a salt thereof as an active ingredient, a therapeutic agent for pain containing the compound or a salt thereof as an active ingredient, and a therapeutic agent for lower urinary tract dysfunction containing the compound or a salt thereof as an active ingredient.
-
9.
公开(公告)号:EP3215510B1
公开(公告)日:2023-06-07
申请号:EP15856978.0
申请日:2015-11-06
IPC分类号: C07D487/04 , A61K31/519 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P43/00 , C07D519/00 , A61K31/13 , A61K31/16
-
公开(公告)号:EP3555100B1
公开(公告)日:2023-05-10
申请号:EP17891696.1
申请日:2017-12-20
IPC分类号: C07D487/14 , A61K31/13 , A61K45/06 , A61P25/28 , A61K31/5517 , A61P25/00 , A61P35/00
-
-
-
-
-
-
-
-
-